| Literature DB >> 35158001 |
Dayoung Ko1, Rebecca F Wang1, David Ozog1, Henry W Lim1, Tasneem F Mohammad2.
Abstract
Key challenges in the management of pigmentary disorders such as melasma and post-inflammatory hyperpigmentation (PIH) are their resistance to treatment, tendency to recur after treatment, and the risk of exacerbating hyperpigmentation with many treatment modalities. The second article in this two-part continuing medical education series on pigmentary disorders focuses on the evidence behind medical and procedural treatments of dyschromias, including photoprotection, topical lightening agents, oral agents, chemical peels, and laser therapy.Entities:
Keywords: ablative fractionated lasers; chemical peels; hydroquinone; intense pulsed light; lasers; lightening cosmeceuticals; melasma; non-ablative fractionated lasers; oral lightening agents; photoprotection; picosecond lasers; pigmentary disorders; post-inflammatory hyperpigmentation; q-switched lasers; sunscreen; topical lightening agents
Year: 2022 PMID: 35158001 DOI: 10.1016/j.jaad.2021.12.065
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527